Deborah Ristvedt, DO
Ophthalmology · Alexandria, MNNPI 1871881656
Payments from drug & device makers
Across 571 payments — averaging $2203.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$618K
- Glaukos Corporation$350K
- Beaver-visitec International, Inc.$154K
- Sight Sciences, Inc.$63K
- AbbVie$37K
- Alcon Research LLC$13K
- plus $24K from 17 others
Across 13 payments — averaging $18,586 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beaver-visitec International, Inc.$238K
- Rxsight Inc$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 192 | $617,989 |
| Glaukos Corporation | 157 | $350,210 |
| Beaver-visitec International, Inc. | 2 | $153,617 |
| Sight Sciences, Inc. | 65 | $63,037 |
| AbbVie(2 entities) | 57 | $36,954 |
| Alcon Research LLC | 12 | $12,566 |
| Alcon | 55 | $9,626 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $5,743 |
| Rayner Intraocular Lenses Limited | 5 | $3,958 |
| Tarsus Pharmaceuticals, Inc. | 2 | $1,588 |
| Novartis | 4 | $1,296 |
| Thea Pharma Inc. | 1 | $975 |
| Johnson & Johnson Vision Care, Inc. | 2 | $198 |
| Harrow Eye, LLC | 3 | $76 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Aerie Pharmaceuticals, Inc. | 1 | $50 |
| Omeros Corporation | 1 | $41 |
| Oyster Point Pharma, Inc. | 2 | $34 |
| Biotissue Holdings Inc. | 2 | $34 |
| Dompe US, Inc. | 1 | $34 |
| The Cameron-ehlen Group, Inc. | 1 | $22 |
| NEW World Medical,inc. | 1 | $16 |
| Amgen | 1 | $14 |
How this compares
$1,258,141 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Alexandria
- Edwin RyanMinneapolis$9.6M
- Richard LindstromBloomington$9M
- Mark LobanoffSt Louis Park$7M
- Robert MittraMinneapolis$5.1M
- David ParkeMinneapolis$4.5M
- Yun-Sen ChuBloomington$1.7M
- John DaviesMinneapolis$1.3M
- Sundeep DevMinneapolis$673K
- Jeffrey FischerWillmar$507K
- Thomas SamuelsonMinnetonka$473K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.